Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Karn

Showing results (21-30 of 106) with videos related to

Pageof 11
Sort By:
Journal of Cancer Research and Clinical Oncology|January 7, 2009
Gene expression of ceramide kinase, galactosyl ceramide synthase and ganglioside GD3 synthase is associated with prognosis in breast cancerEugen Ruckhäberle, Thomas Karn, Achim Rody, et al.
Journal of Cancer Research and Clinical Oncology|June 19, 2008
Prognostic relevance of glucosylceramide synthase (GCS) expression in breast cancerEugen Ruckhäberle, Thomas Karn, Lars Hanker, et al.
Breast Cancer Research and Treatment|November 9, 2012
Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancerKarin Milde-Langosch, Thomas Karn, Volkmar Müller, et al.
Gynecologic and Obstetric Investigation|June 1, 2026
Interdisciplinary Implementation of the International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome (PCOS): Care Gaps and Knowledge Deficits in Key High-Burden DomainsAnnette Bachmann, Sandra Jordan, Thomas Karn, et al.
Archives of Gynecology and Obstetrics|January 25, 2025
Unmet clinical needs in women with polycystic ovary syndrome regarding fertility and obesity: a cross-sectional study from the patient's perspectiveAnnette Bachmann, Susanna Weidlinger, Michael von Wolff, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|March 23, 2013
Acid ceramidase (AC)--a key enzyme of sphingolipid metabolism--correlates with better prognosis in epithelial ovarian cancerLars Christian Hanker, Thomas Karn, Uwe Holtrich, et al.
Gynecologic and Obstetric Investigation|August 4, 2025
Prognostic Impact of Estrogen and Progesterone Receptor Expression Across Histological Subtypes and Clinical Factors in Epithelial Ovarian CancerKhayal Gasimli, Alice Melodie Wilke, Iryna Schmeil, et al.
Molecular and Clinical Oncology|October 5, 2016
Trefoil factor 3 expression in epithelial ovarian cancer exerts a minor effect on clinicopathological parametersFriederike Hoellen, Athina Kostara, Thomas Karn, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|October 24, 2007
Expression of membrane-type 5 matrix metalloproteinase in human endometrium and endometriosisRegine Gaetje, Uwe Holtrich, Knut Engels, et al.
Anticancer Research|February 9, 2013
Prognostic impact of fascin-1 (FSCN1) in epithelial ovarian cancerLars C Hanker, Thomas Karn, Uwe Holtrich, et al.
Pageof 11

Showing results (21-30 of 106) with videos related to

Sort By:
Pageof 11
Journal of Cancer Research and Clinical Oncology|January 7, 2009
Gene expression of ceramide kinase, galactosyl ceramide synthase and ganglioside GD3 synthase is associated with prognosis in breast cancerEugen Ruckhäberle, Thomas Karn, Achim Rody, et al.
Journal of Cancer Research and Clinical Oncology|June 19, 2008
Prognostic relevance of glucosylceramide synthase (GCS) expression in breast cancerEugen Ruckhäberle, Thomas Karn, Lars Hanker, et al.
Breast Cancer Research and Treatment|November 9, 2012
Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancerKarin Milde-Langosch, Thomas Karn, Volkmar Müller, et al.
Gynecologic and Obstetric Investigation|June 1, 2026
Interdisciplinary Implementation of the International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome (PCOS): Care Gaps and Knowledge Deficits in Key High-Burden DomainsAnnette Bachmann, Sandra Jordan, Thomas Karn, et al.
Archives of Gynecology and Obstetrics|January 25, 2025
Unmet clinical needs in women with polycystic ovary syndrome regarding fertility and obesity: a cross-sectional study from the patient's perspectiveAnnette Bachmann, Susanna Weidlinger, Michael von Wolff, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|March 23, 2013
Acid ceramidase (AC)--a key enzyme of sphingolipid metabolism--correlates with better prognosis in epithelial ovarian cancerLars Christian Hanker, Thomas Karn, Uwe Holtrich, et al.
Gynecologic and Obstetric Investigation|August 4, 2025
Prognostic Impact of Estrogen and Progesterone Receptor Expression Across Histological Subtypes and Clinical Factors in Epithelial Ovarian CancerKhayal Gasimli, Alice Melodie Wilke, Iryna Schmeil, et al.
Molecular and Clinical Oncology|October 5, 2016
Trefoil factor 3 expression in epithelial ovarian cancer exerts a minor effect on clinicopathological parametersFriederike Hoellen, Athina Kostara, Thomas Karn, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|October 24, 2007
Expression of membrane-type 5 matrix metalloproteinase in human endometrium and endometriosisRegine Gaetje, Uwe Holtrich, Knut Engels, et al.
Anticancer Research|February 9, 2013
Prognostic impact of fascin-1 (FSCN1) in epithelial ovarian cancerLars C Hanker, Thomas Karn, Uwe Holtrich, et al.
Pageof 11